Morphic Therapeutic to Present at the 40th Annual Cowen Health Care Conference
28 févr. 2020 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...